MAN2A2

MAN2A2 (alpha-mannosidase IIx) is a Golgi-resident glycan-processing enzyme that trims mannose residues from N-glycan intermediates during the maturation of N-linked glycans, functioning as an isozyme of Golgi alpha-mannosidase II (PMID:8524845). Although its intrinsic in vitro mannosidase activity is minimal, MAN2A2 is essential in vivo for generating the GlcNAc-terminated complex-type N-glycans that depend on its activity (PMID:8524845, PMID:12417422). Together with MAN2A1, MAN2A2 is required for the conversion of hybrid- to complex-type N-glycans, since loss of both enzymes abolishes complex N-glycan formation and traps proteins as hybrid-type (PMID:33878161). Within the Golgi, MAN2A2 organizes glycan processing as a central hub in multi-enzyme assemblies, forming distinct complexes with MGAT1, MGAT2, MGAT3, and MGAT4B (PMID:30737517), and it generates the substrate acted on downstream by MGAT2 (PMID:39364139). The enzyme is critically required for male fertility: its loss in mice blocks spermatogenesis by depleting a GlcNAc-terminated tri-antennary fucosylated N-glycan that mediates germ cell–Sertoli cell adhesion (PMID:11778047, PMID:12417422, PMID:39364139). In humans, loss-of-function and compound heterozygous variants in MAN2A2 cause a congenital disorder of glycosylation with neurological involvement, characterized by reduced complex N-glycans and accumulation of hybrid-type N-glycans (PMID:36357165, PMID:40628855).

1. 1995 High

   Established MAN2A2 as a distinct, catalytically active alpha-mannosidase II isozyme acting in N-glycan processing, answering whether the gene encoded a functional glycosidase.

   Evidence cDNA cloning and COS cell transfection with alpha-mannosidase activity assay, plus chromosomal mapping to 15q25

   PMID:8524845

   Open questions at the time

   • In vivo substrate and physiological role not addressed
   • Subcellular localization within the Golgi not directly demonstrated here
2. 1996 Medium

   Defined the transcriptional architecture of MAN2A2 by mapping its TATA-less, CpG-island promoter and regulatory elements, clarifying how the gene is expressed.

   Evidence Primer extension and luciferase reporter assays with deletion constructs in human melanoma cells

   PMID:9022667

   Open questions at the time

   • Tissue-specific regulation not resolved
   • Trans-acting factors beyond an Sp1-like site not identified
3. 2002 High

   Revealed the essential in vivo function of MAN2A2 in spermatogenesis and identified the specific glycan it produces, despite minimal in vitro activity, resolving the paradox between weak biochemical activity and biological importance.

   Evidence Man2a2 knockout mice with histology, electron microscopy, N-glycan structural analysis, in vitro adhesion reconstitution with purified glycans, and direct in vitro enzyme assay

   PMID:11778047 PMID:12417422

   Open questions at the time

   • Mechanism reconciling minimal in vitro activity with essential in vivo role not fully explained
   • Whether Sertoli cell receptor for the adhesion glycan is identified is unaddressed
4. 2019 Medium

   Positioned MAN2A2 as an organizing hub of Golgi glycosylation machinery by mapping its physical partnerships with specific GlcNAc-transferases, addressing how processing enzymes are spatially coordinated.

   Evidence High-throughput FRET- and BiFC-based live-cell interaction screens in HEK cells

   PMID:30737517

   Open questions at the time

   • Functional consequence of each complex on glycan output not measured
   • Stoichiometry and structural basis of the assemblies unknown
   • Single-lab live-cell methods without orthogonal biochemical validation
5. 2021 Medium

   Demonstrated that MAN2A1 and MAN2A2 together are required for the hybrid-to-complex N-glycan transition in human cells, defining their combined pathway necessity.

   Evidence CRISPR/Cas9 double knockout in HEK293 cells with mass spectrometry glycan analysis of recombinant proteins

   PMID:33878161

   Open questions at the time

   • Combined knockout does not isolate the MAN2A2-specific contribution
   • Single cell line and single lab
6. 2022 High

   Linked MAN2A2 loss-of-function to a human congenital disorder of glycosylation, establishing direct clinical relevance of the enzyme's glycan-processing role.

   Evidence Exome sequencing identifying p.Val1101Ter, patient lymphoblast N-glycan analysis, and complementation in MAN2A1/MAN2A2 double-KO HEK293 cells

   PMID:36357165

   Open questions at the time

   • Genotype-phenotype spectrum across patients not defined
   • Mechanistic basis of neurological involvement not resolved
7. 2024 Medium

   Placed MAN2A2 upstream of MGAT2 in a defined glycan-processing pathway during spermatogenesis through genetic epistasis, distinguishing the consequences of disrupting sequential steps.

   Evidence Conditional Mgat2 knockout, lectin-binding assays, RNA-seq, AKT/ERK signaling Western blots, and epistasis comparison with Man2a2 and Mgat1 knockouts

   PMID:39364139

   Open questions at the time

   • Direct enzymatic substrate-product chain not biochemically reconstituted
   • Signaling consequences downstream of altered glycosylation incompletely defined
   • Single lab
8. 2025 Medium

   Extended the human phenotypic spectrum of MAN2A2 dysfunction to autism and cognitive delay via compound heterozygous variants, reinforcing the link between Golgi N-glycan processing and neurodevelopment.

   Evidence Whole-exome sequencing, serum glycoprotein N-glycan analysis, and in silico structural prediction

   PMID:40628855

   Open questions at the time

   • Single case limits generalization
   • Structural predictions are in silico only and not experimentally validated
   • Causal link between glycan changes and neurodevelopmental phenotype not directly established

• How MAN2A2's minimal intrinsic catalytic activity is functionally amplified within Golgi multi-enzyme complexes to drive complex N-glycan formation in vivo remains unresolved.
• No reconstituted biochemical mechanism explaining in vivo efficacy
• Structural basis of MAN2A2–MGAT complexes unknown
• Substrate channeling within Golgi assemblies not demonstrated